Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.

van Doremalen N, Lambe T, Sebastian S, Bushmaker T, Fischer R, Feldmann F, Haddock E, Letko M, Avanzato VA, Rissanen I, LaCasse R, Scott D, Bowden TA, Gilbert S, Munster V.

PLoS Negl Trop Dis. 2019 Jun 6;13(6):e0007462. doi: 10.1371/journal.pntd.0007462. [Epub ahead of print]

2.

Bactrian camels shed large quantities of Middle East respiratory syndrome coronavirus (MERS-CoV) after experimental infection.

Adney DR, Letko M, Ragan IK, Scott D, van Doremalen N, Bowen RA, Munster VJ.

Emerg Microbes Infect. 2019;8(1):717-723. doi: 10.1080/22221751.2019.1618687.

3.

SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (Rousettus aegyptiacus).

van Doremalen N, Schäfer A, Menachery VD, Letko M, Bushmaker T, Fischer RJ, Figueroa DM, Hanley PW, Saturday G, Baric RS, Munster VJ.

Viruses. 2018 Dec 19;10(12). pii: E727. doi: 10.3390/v10120727.

4.

Adaptive Evolution of MERS-CoV to Species Variation in DPP4.

Letko M, Miazgowicz K, McMinn R, Seifert SN, Sola I, Enjuanes L, Carmody A, van Doremalen N, Munster V.

Cell Rep. 2018 Aug 14;24(7):1730-1737. doi: 10.1016/j.celrep.2018.07.045.

5.

Single-Nucleotide Polymorphisms in Human NPC1 Influence Filovirus Entry Into Cells.

Kondoh T, Letko M, Munster VJ, Manzoor R, Maruyama J, Furuyama W, Miyamoto H, Shigeno A, Fujikura D, Takadate Y, Yoshida R, Igarashi M, Feldmann H, Marzi A, Takada A.

J Infect Dis. 2018 Nov 22;218(suppl_5):S397-S402. doi: 10.1093/infdis/jiy248.

PMID:
30010949
6.

The Structural Interface between HIV-1 Vif and Human APOBEC3H.

Ooms M, Letko M, Simon V.

J Virol. 2017 Feb 14;91(5). pii: e02289-16. doi: 10.1128/JVI.02289-16. Print 2017 Mar 1.

7.

Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes.

Reddy K, Ooms M, Letko M, Garrett N, Simon V, Ndung'u T.

AIDS. 2016 Jul 17;30(11):1723-9. doi: 10.1097/QAD.0000000000001113.

8.

Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.

Letko M, Booiman T, Kootstra N, Simon V, Ooms M.

Cell Rep. 2015 Dec 1;13(9):1789-99. doi: 10.1016/j.celrep.2015.10.068. Epub 2015 Nov 25.

9.

Origin of the HIV-1 group O epidemic in western lowland gorillas.

D'arc M, Ayouba A, Esteban A, Learn GH, Boué V, Liegeois F, Etienne L, Tagg N, Leendertz FH, Boesch C, Madinda NF, Robbins MM, Gray M, Cournil A, Ooms M, Letko M, Simon VA, Sharp PM, Hahn BH, Delaporte E, Mpoudi Ngole E, Peeters M.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1343-52. doi: 10.1073/pnas.1502022112. Epub 2015 Mar 2.

10.

HIV-1 Vif adaptation to human APOBEC3H haplotypes.

Ooms M, Brayton B, Letko M, Maio SM, Pilcher CD, Hecht FM, Barbour JD, Simon V.

Cell Host Microbe. 2013 Oct 16;14(4):411-21. doi: 10.1016/j.chom.2013.09.006.

11.

APOBEC3G polymorphism as a selective barrier to cross-species transmission and emergence of pathogenic SIV and AIDS in a primate host.

Krupp A, McCarthy KR, Ooms M, Letko M, Morgan JS, Simon V, Johnson WE.

PLoS Pathog. 2013;9(10):e1003641. doi: 10.1371/journal.ppat.1003641. Epub 2013 Oct 3.

12.

Vif proteins from diverse primate lentiviral lineages use the same binding site in APOBEC3G.

Letko M, Silvestri G, Hahn BH, Bibollet-Ruche F, Gokcumen O, Simon V, Ooms M.

J Virol. 2013 Nov;87(21):11861-71. doi: 10.1128/JVI.01944-13. Epub 2013 Aug 28.

13.

The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.

Ooms M, Letko M, Binka M, Simon V.

PLoS One. 2013;8(2):e57744. doi: 10.1371/journal.pone.0057744. Epub 2013 Feb 28.

14.

Midline crossing is not required for subsequent pathfinding decisions in commissural neurons.

Bonner J, Letko M, Nikolaus OB, Krug L, Cooper A, Chadwick B, Conklin P, Lim A, Chien CB, Dorsky RI.

Neural Dev. 2012 Jun 6;7:18. doi: 10.1186/1749-8104-7-18.

15.

Comparative analysis of the effect of preparations used in professional fluoride prophylaxis on the chosen parameters of human saliva.

Balunowska M, Dabrowska E, Letko M, Roszkowska-Jakimiec W, Letko J, Jamiołkowski J.

Adv Med Sci. 2006;51 Suppl 1:114-8.

PMID:
17458073
16.

Effect of chlorhexidine mouthrinse on cathepsin C activity in human saliva.

Dabrowska E, Letko M, Roszkowska-Jakimiec W, Letko R, Sadowski J.

Adv Med Sci. 2006;51 Suppl 1:96-9.

PMID:
17458068
17.

Effect of fluoride preparations on the activity of human salivary cathepsin C.

Dabrowska E, Letko M, Roszkowska-Jakimiec W, Letko R, Jamiołkowski J.

Rocz Akad Med Bialymst. 2005;50 Suppl 1:160-2.

PMID:
16119654
18.

Notes on oximeter.

Letko MD.

J Perinatol. 1996 Nov-Dec;16(6):514. No abstract available.

PMID:
8979198
19.

Understanding the Apgar score.

Letko MD.

J Obstet Gynecol Neonatal Nurs. 1996 May;25(4):299-303.

PMID:
8708830
20.

Pulse oximetry.

Letko MD.

J Obstet Gynecol Neonatal Nurs. 1992 Sep-Oct;21(5):350-1. No abstract available.

PMID:
1403219
21.

Detecting and preventing infant hearing loss.

Letko MD.

Neonatal Netw. 1992 Aug;11(5):33-8. No abstract available.

PMID:
1495465

Supplemental Content

Support Center